HIF1A and gastric cancer: Herein, we demonstrate that Crenigacestat effectiveness in CD90 positive cells could be mediated by AKT signaling, in agreement with the study by Gao et al.[20], in which the authors showed that CD90 affects biological behavior and levels of energy metabolism of gastric cancer cells through activation of the PI3K/AKT/HIF-1α signaling pathway.